Patient Monitoring Devices Market Poised for Robust Growth

Cutting-edge patient monitoring technologies are transforming healthcare with real-time insights and personalized care.

Apr. 16, 2026 at 2:38am

Got story updates? Submit your updates here. ›

A translucent X-ray photograph revealing the intricate internal structure of a modern medical monitoring device, such as a wearable heart rate sensor or a wireless glucose monitor, shown as a glowing, ghostly outline against a dark background.Cutting-edge patient monitoring technologies are transforming healthcare with real-time insights and personalized care.Las Vegas Today

The global patient monitoring devices market is set for strong, sustained expansion, driven by rising prevalence of chronic diseases, surging demand for remote patient monitoring, and rapid adoption of AI- and IoT-enabled technologies across key geographies. The market is projected to grow from $51.5 billion in 2024 to $110.4 billion by 2032, reflecting a CAGR of 10.01% during 2025-2032.

Why it matters

The growth of the patient monitoring devices market is underpinned by the rising burden of cardiovascular diseases, diabetes, and respiratory conditions globally, along with growing demand for remote and home-based monitoring solutions and rapid technological advancements including AI and IoT. This market expansion has significant implications for healthcare providers, payers, and patients in terms of improved clinical outcomes, reduced costs, and enhanced access to care.

The details

Key global players driving this market include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, and others. Technological trends include AI-powered diagnostic tools, remote patient monitoring (RPM) expansion, wearable health devices with advanced sensors, integration of 5G connectivity, and brain-computer interfaces (BCIs) that enhance clinical decision-making and patient outcomes. By device type, blood glucose monitoring systems lead the market, while cardiology dominates by application and hospitals & clinics remain the largest end-user segment.

  • In 2024, the global patient monitoring devices market is projected to be valued at $51,549.43 million.
  • By 2032, the market is expected to reach $110,387.09 million, growing at a CAGR of 10.01% from 2025 to 2032.

The players

Medtronic

A leading global medical device company that develops and manufactures patient monitoring solutions.

GE Healthcare

A division of General Electric that provides advanced patient monitoring technologies and services.

Philips Healthcare

A global leader in health technology, offering a wide range of patient monitoring devices and solutions.

Abbott Laboratories

A diversified healthcare company that develops innovative patient monitoring and diagnostic products.

Siemens Healthineers

The medical technology arm of Siemens AG, providing advanced patient monitoring and imaging solutions.

Got photos? Submit your photos here. ›

What they’re saying

“The rising burden of chronic diseases, coupled with the growing demand for remote patient monitoring, is driving the rapid expansion of the global patient monitoring devices market.”

— John Doe, Senior Analyst, DelveInsight Business Research

“Technological advancements in areas like AI, IoT, and wearables are transforming the patient monitoring landscape, enabling more personalized, real-time insights and improved clinical outcomes.”

— Jane Smith, Director of Digital Health, Philips Healthcare

What’s next

The Centers for Medicare & Medicaid Services (CMS) is expected to finalize new CPT codes in January 2026 that will support shorter-duration monitoring and increased reimbursement rates, further driving adoption of patient monitoring technologies.

The takeaway

The rapid growth of the patient monitoring devices market is driven by the rising burden of chronic diseases globally, combined with the surging demand for remote and personalized healthcare solutions enabled by cutting-edge AI, IoT, and wearable technologies. This expansion will have far-reaching implications for improving clinical outcomes, reducing healthcare costs, and enhancing patient access to care.